About Us >

About Us

The UAB/UMN SPORE in Pancreatic Cancer is committed to reducing the morbidity and mortality of pancreatic cancer by increasing our understanding of the molecular basis of the disease and developing novel treatments to combat it. This program is designed to draw upon the advances in genomic medicine and the promise of new anti-cancer agents pioneered by researchers at the University of Alabama at Birmingham (UAB) and the University of Minnesota (UMN).
The UAB/UMN SPORE in Pancreatic Cancer supports interdisciplinary and translational pancreatic cancer research with targeted research in efforts in diagnosis and progression and novel therapeutic strategies.
The UAB/UMN SPORE in Pancreatic Cancer brings together nationally and internationally recognized pancreatic cancer scientists and clinicians to move research findings quickly and safely from the laboratory to the clinical setting.
The UAB/UMN SPORE in Pancreatic Cancer’s multidisciplinary approach to pancreatic cancer treatment provides access to a team of dedicated specialists, including gastroenterologists, medical oncologists, radiation oncologists, surgical oncologists, pathologists, and radiologists, who work together to design the most effective treatment plan possible.
The UAB/UMN SPORE in Pancreatic Cancer has developed outstanding interactions with the pancreatic cancer patients, survivors, family members and volunteer advocates who are assisting the UAB/UMN SPORE in Pancreatic Cancer in its translational research                                                        efforts and are sharing their experiences with other pancreatic cancer patients and their families.

Image text